Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2020 08:04 ET | Source: Optinose, Inc.

Optinose Announces Pricing of Public Offering of Common Stock

YARDLEY, Pa., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, today announced the...
August 13, 2020 16:26 ET | Source: Optinose, Inc.

Optinose Announces Proposed Public Offering of Common Stock

YARDLEY, Pa., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, today announced the...
August 04, 2020 07:00 ET | Source: Optinose, Inc.

Optinose Reports Second Quarter 2020 Financial Results and Recent Operational Highlights

Company reports second quarter 2020 XHANCE net revenue of $10.3 million Second quarter 2020 XHANCE prescriptions increased 84% from second quarter 2019 Conference call and webcast to be held today...
July 30, 2020 16:01 ET | Source: Optinose, Inc.

Optinose Announces Reporting Date for Second Quarter 2020 Financial Results

YARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
July 29, 2020 16:01 ET | Source: Optinose, Inc.

Optinose names Catherine E. Owen as Director

YARDLEY, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
July 08, 2020 16:15 ET | Source: Optinose, Inc.

Optinose Announces XHANCE Co-Promotion Agreement with Kaléo

YARDLEY, Pa., July 08, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
June 30, 2020 08:00 ET | Source: Optinose, Inc.

Optinose Announces Anti-COVID-19 Product Candidate

YARDLEY, Pa., June 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
June 22, 2020 08:30 ET | Source: Optinose, Inc.

Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

YARDLEY, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
June 19, 2020 10:00 ET | Source: Optinose, Inc.

Optinose Named a 2020 Best Place to Work by Philadelphia Business Journal

YARDLEY, Pa., June 19, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
May 27, 2020 16:30 ET | Source: Optinose, Inc.

Optinose to Host its Annual Meeting of Stockholders in Virtual Format

YARDLEY, Pa., May 27, 2020 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN) today announced that due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and...